Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 20, 2023
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
[ Wed, Sep 20th 2023
] - WOPRAI
Tue, September 19, 2023
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
[ Tue, Sep 19th 2023
] - WOPRAI
Kyle Mikson Reiterated (TXG) at Strong Buy and Held Target at $70 on, Sep 19th, 2023
Kyle Mikson of Canaccord Genuity, Reiterated "10x Genomics, Inc." (TXG) at Strong Buy and Held Target at $70 on, Sep 19th, 2023.
Kyle has made no other calls on TXG in the last 4 months.
There are 4 other peers that have a rating on TXG. Out of the 4 peers that are also analyzing TXG, 0 agree with Kyle's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Kyle
- Tejas Savant of "Morgan Stanley" Reiterated at Buy and Held Target at $65 on, Monday, August 7th, 2023
- Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Increased Target to $75 on, Friday, August 4th, 2023
- Luke Sergott of "Barclays" Maintained at Buy with Increased Target to $66 on, Friday, August 4th, 2023
- Matthew Sykes of "Goldman Sachs" Maintained at Strong Sell with Increased Target to $30 on, Thursday, July 13th, 2023
